• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Acute Ischemic Stroke - Pipeline Review, Q1 2011 - Product Image

Acute Ischemic Stroke - Pipeline Review, Q1 2011

  • ID: 1574065
  • February 2011
  • 61 pages
  • Global Markets Direct

Acute Ischemic Stroke - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Acute Ischemic Stroke - Pipeline Review, Q1 2011', provides an overview of the Acute Ischemic Stroke therapeutic pipeline. This report provides information on the therapeutic development for Acute Ischemic Stroke, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Ischemic Stroke. 'Acute Ischemic Stroke - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Acute Ischemic Stroke.
- A review of the Acute Ischemic Stroke products under development by companies and READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Acute Ischemic Stroke Overview
Therapeutics Development
An Overview of Pipeline Products for Acute Ischemic Stroke
Acute Ischemic Stroke Therapeutics under Development by Companies
Acute Ischemic Stroke Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in Acute Ischemic Stroke Therapeutics Development
Shionogi & Co., Ltd.
Sanofi-Aventis
Aldagen, Inc.
H Lundbeck A/S
Mitsubishi Tanabe Pharma Corporation
Pfizer Inc.
Celgene Corporation
Vernalis plc
ReNeuron Group plc
SYGNIS Pharma AG
ThromboGenics NV
Stem Cell Therapeutics Corp.
Daiichi Sankyo, Inc.
D-Pharm Ltd.
BioMAS Ltd.
Ferrer Internacional S.A.
M's Science Corporation
Gaia BioPharma Limited
Universities/Institutes Involved in Acute Ischemic Stroke Therapeutics Development
Acute Ischemic Stroke - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Companies
Citicoline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Desmoteplase - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DP-b99 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles – Universities/Institutes
Alteplase + Uric Acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Clopidogrel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Dapsone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
donepezil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Escitalopram - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Human serum albumin infusion - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Noscapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
propofol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Propranolol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Tissue Plasminogen Activator - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
Acute Ischemic Stroke - Featured News
1. Dec 23, 2010: Angel To Further Produce ReN001 Stem Cells Batches For PISCES Phase I Clinical Trial
2. Dec 22, 2010: SYGNIS Announces Data Safety Monitoring Board Recommendation For Phase II Study Of AX200
3. Dec 22, 2010: Stem Cell Therapeutics Announces Outcome Of End Of Phase II Meeting With FDA
4. Dec 08, 2010: Stem Cell Therapeutics Wins US Patent Relating To NTx-265
5. Nov 16, 2010: ReNeuron Reports First Patient Treated In Landmark Stroke Stem Cell Clinical Trial
6. Nov 03, 2010: D-Pharm Appoints CRO For Clinical Development Of DP-b99 In China
7. Oct 19, 2010: Acorda Reports Preclinical Study Data Of GGF2 In Treatment Of Focal Ischemic Stroke
8. Oct 02, 2010: ReNeuron receives final regulatory approval to commence landmark stroke clinical trial in UK.
9. Aug 10, 2010: D-Pharm Reports Positive Results From Phase III Cardiac Safety Study With DP-b99
10. Jul 19, 2010: RegeneRx' TB4 Shows Improvement In Neurological Function After Stroke
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Acute Ischemic Stroke, 2011
Products under Development for Acute Ischemic Stroke – Comparative Analysis, 2011
Comparative Analysis by Late Stage Development, 2011
Comparative Analysis by Mid Clinical Stage Development, 2011
Comparative Analysis by Early Clinical Stage Development, 2011
Comparative Analysis by Pre-Clinical Stage Development, 2011
Shionogi & Co., Ltd., 2011
Sanofi-Aventis, 2011
Aldagen, Inc., 2011
H Lundbeck A/S, 2011
Mitsubishi Tanabe Pharma Corporation, 2011
Pfizer Inc., 2011
Celgene Corporation, 2011
Vernalis plc, 2011
ReNeuron Group plc, 2011
SYGNIS Pharma AG, 2011
ThromboGenics NV, 2011
Stem Cell Therapeutics Corp., 2011
Daiichi Sankyo, Inc., 2011
D-Pharm Ltd., 2011
BioMAS Ltd., 2011
Ferrer Internacional S.A., 2011
M's Science Corporation, 2011
Gaia BioPharma Limited, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Discontinued Products

List of Figures
Number of Products under Development for Acute Ischemic Stroke, 2011
Products under Development for Acute Ischemic Stroke – Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Late Stage Products, 2011
Mid Clinical Stage Products, 2011
Early Clinical Stage Products, 2011
Pre-Clinical Stage Products, 2011
Assessment by Monotherapy Products, 2011
Assessment by Combination Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos